Articles

Page 62 of 94

P15-30 LB. An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials

Authors: D Johnson, Y Merino, N Berkowitz, O Vasilenko, B Larkin, S Young, B Graham and JM Ledgerwood

Citation: Retrovirology 2009 6(Suppl 3):P406

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial

Authors: Y Shao, T Li, H Wolf, Y Liu, Y Liu, H Wang, H Zhu, W Lv, W Lin, J Chen, H Liang, K Hong and M Jia

Citation: Retrovirology 2009 6(Suppl 3):P404

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

Authors: A Pegu, T Migone, W Freimuth, M Donaldson, K Foulds, M Roederer and GJ Nabel

Citation: Retrovirology 2009 6(Suppl 3):P402

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P09-19 LB. CTL escape mutations in gag epitopes restricted by protective HLA class I alleles cause substantial reductions in viral replication capacity

Authors: CL Boutwell, A Schneidewind, Z Brumme, M Brockman, H Streeck, C Brumme, T Dudek, K Kane, M Kemper, B Walker, M Altfeld and T Allen

Citation: Retrovirology 2009 6(Suppl 3):P399

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P20-02. Characterization of phenotypic, genotypic and neutralization sensitivity of the HIV-1 CRF07_B'C Strains circulating in the Xinjiang Province of China

Authors: L Ma, Y Guo, J Sun, L Yuan, Y Huang, S Qu, X Yu, Z Meng, X He, S Jiang and Y Shao

Citation: Retrovirology 2009 6(Suppl 3):P372

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies

Authors: K Wiehe, TB Kepler and SC Schmidler

Citation: Retrovirology 2009 6(Suppl 3):P370

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

Authors: G Spies, J Simandl, D Casimiro, O DeFawe, L Noonan, N Frahm and MJ McElrath

Citation: Retrovirology 2009 6(Suppl 3):P368

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques

Authors: KA Kraynyak, MA Kutzler, B Pahar, A Sylvester, J Yan, D Carnathan, AS Khan, N Sardesai, Z Moldoveanu, J Mestecky, MR Betts, P Marx and DB Weiner

Citation: Retrovirology 2009 6(Suppl 3):P366

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-15. Synthesis of multivalent mimotopes as potential vaccine candidates

Authors: JG Go, JP Saludes, JA Hoch, JW Oliver and J Gervay-Hague

Citation: Retrovirology 2009 6(Suppl 3):P335

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-13. Recombinant proteins carrying peptide mimics of HIV-1

Authors: A Chikaev, N Scherbakova, O Tumanova, L Karpenko and A Ilyichev

Citation: Retrovirology 2009 6(Suppl 3):P333

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies

Authors: M Visciano, M Tagliamonte, M Tornesello, L Lopalco, F Buonaguro and L Buonaguro

Citation: Retrovirology 2009 6(Suppl 3):P331

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-09. Site-specific incorporation of an unnatural amino acid into the HIV-1 Env spike

Authors: SO Arnett and DR Burton

Citation: Retrovirology 2009 6(Suppl 3):P329

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-07. Development of a protective HIV/SIV vaccine based on a self-boosting cytomegalovirus vector

Authors: A Ambagala, DO Willer, J Chan, A Marsh, P Sandstrom, R Pilon, J Fournier and KS MacDonald

Citation: Retrovirology 2009 6(Suppl 3):P327

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-18. ANRS lipo5 sequences induce in vitro cross-reactive CD4+ T cell response against clade B and C

Authors: FA Castelli, N Szely and B Maillère

Citation: Retrovirology 2009 6(Suppl 3):P300

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Authors: N Saubi, E Im, R Fernandez-Lloris, O Gil, P Cardona, J Gatell, T Hanke and J Joseph

Citation: Retrovirology 2009 6(Suppl 3):P299

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen

Authors: D Franco, C Rosas, CM Rice and DD Ho

Citation: Retrovirology 2009 6(Suppl 3):P297

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-13. Hexon hypervariable regions 4–7 contain important Ad5-specific neutralizing antibody epitopes

Authors: RR Bradley, LF Maxfield and DH Barouch

Citation: Retrovirology 2009 6(Suppl 3):P295

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-35. Specific CD4 responses to HIV-1 epitopes in exposed seronegative (ESN) versus infected commercial sex workers

Authors: MW Kiguoya, J Mwanjewe, B Ball, K Makubo, J Kimani and K Fowke

Citation: Retrovirology 2009 6(Suppl 3):P264

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-33. Standardized serum-free cryomedia have minimum cytotoxicity and maintain antigen-specific T-cell response

Authors: JC Schulz, H Zimmermann, A Reich, B Kemp-Kampke, H von Briesen and A Germann

Citation: Retrovirology 2009 6(Suppl 3):P262

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses

Authors: M Montes, N Loof, A Cobb, D Jutras, C Queen, J Plants, B King, S Zurawski, L Sloan, Y Levy and J Banchereau

Citation: Retrovirology 2009 6(Suppl 3):P258

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama

Authors: SB Alexander and S Im

Citation: Retrovirology 2009 6(Suppl 3):P227

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-24. Good participatory practice guidelines begin to take root

Authors: L Miller, E Bass, M Warren, D Grant, A Costelloe-Kuehn, C Feuer and K Fisher

Citation: Retrovirology 2009 6(Suppl 3):P225

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis

Authors: V Sarazin and P Milsom

Citation: Retrovirology 2009 6(Suppl 3):P223

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations

Authors: C Lau, EM Swann, P Gaist and MA Allen

Citation: Retrovirology 2009 6(Suppl 3):P219

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

Authors: P Pitisuttithum, S Rerks-Ngarm, J Kaewkungwal, S Nitayaphan, C Khamboonruang, P Kunasol, P Suntharasamai, MW Benenson and JH Kim

Citation: Retrovirology 2009 6(Suppl 3):P193

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

Authors: S Aboud, F Mhalu, M Bakari, J Lifson, E Lyamuya, M Marovich, J Cox, E Sandstrom, G Biberfeld and C Nilsson

Citation: Retrovirology 2009 6(Suppl 3):P191

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Authors: S Kochhar, J Excler and P Fast

Citation: Retrovirology 2009 6(Suppl 3):P189

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

Authors: M Latka, G Grey, K Fielding, L Bekker, K Mlisana, M Nchabeleng, G DeBruin, M Allen, J Kublin and G Churchyard

Citation: Retrovirology 2009 6(Suppl 3):P187

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C

Authors: C Primard, C Weber, F Martinon, S Munier, A Calamel, E Luciani, T Delair, R Le Grand and B Verrier

Citation: Retrovirology 2009 6(Suppl 3):P160

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140

Authors: L Donnelly, RM Curran, RJ Morrow, VL Kett, GP Andrews, RK Malcolm, AD Woolfson and RJ Shattock

Citation: Retrovirology 2009 6(Suppl 3):P156

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses

Authors: JF Mann, DS Miranda de Stegmann, K Klein, D Stieh, MP Cranage, RJ Shattock and PF McKay

Citation: Retrovirology 2009 6(Suppl 3):P154

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)

Authors: LG Perez, MR Costa and DC Montefiori

Citation: Retrovirology 2009 6(Suppl 3):P152

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes

Authors: DR Kaufman, NL Simmons and DH Barouch

Citation: Retrovirology 2009 6(Suppl 3):P148

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P09-08. The complexity of the infecting inoculum determines the outcome of infection

Authors: L Loh, J Reece, J Petravic, R Center, M Davenport and SJ Kent

Citation: Retrovirology 2009 6(Suppl 3):P121

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape

Authors: PL Moore, N Ranchobe, B Lambson, E Gray, K Mlisana, S Abdool Karim, C Williamson, S Gnanakaran and L Morris

Citation: Retrovirology 2009 6(Suppl 3):P117

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P09-02. Selection pressure of neutralizing antibodies and viral escape continues in late stages of the disease

Authors: P Rusert, A Krarup, B Joos, T Uhr, J Weber, K Herbert, HF Guenthard and A Trkola

Citation: Retrovirology 2009 6(Suppl 3):P115

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-09. 4e10 epitope-scaffolds mimic the antibody-bound epitope conformation and block neutralization by sera from rare HIV+ individuals

Authors: YA Ban, BE Correia, M Holmes, E Boni, N Sather, C Bretz, O Kalyuzhniy, C Xu, D Baker, L Stamatatos, R Strong and W Schief

Citation: Retrovirology 2009 6(Suppl 3):P85

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-07. Evaluation of peripheral and bone marrow B cell responses in rhesus macaques after immunization with soluble HIV-1 gp140 trimers

Authors: C Sundling, M Soldemo, B Chakrabarti, MN Forsell, K Loré, RT Wyatt, I Douagi and GB Karlsson Hedestam

Citation: Retrovirology 2009 6(Suppl 3):P83

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-05. Enhanced immunogenicity of HIV-1 envelope glycoprotein trimers fused to CD40 ligand

Authors: M Melchers, K Matthews, T van Montfort, I Bontjer, D Eggink, R de Vries, E Michael, K David, JP Moore, B Berkhout and RW Sanders

Citation: Retrovirology 2009 6(Suppl 3):P81

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope

Authors: CE Hioe, M Visciano, R Kumar, J Liu and M Tuen

Citation: Retrovirology 2009 6(Suppl 3):P79

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-01. Generation of a HI-viral packaging cell line as scaffolding for a lentiviral display system

Authors: K Schilling, R Wagner and A Kliche

Citation: Retrovirology 2009 6(Suppl 3):P77

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β

Authors: KL Weaver, KK Peachman, K Boonnak, L Wieczorek, GR Matyas, LM Asher, VR Polonis, M Marovich, CR Alving and M Rao

Citation: Retrovirology 2009 6(Suppl 3):P50

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-16. Orally exposed uninfected individuals have systemic anti-HIV response correlating with partner's viral load

Authors: K Hasselrot, G Bratt, T Hirbod, P Säberg, E Sandström and K Broliden

Citation: Retrovirology 2009 6(Suppl 3):P44

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial

Authors: M Rolland, S Tovanabutra, PB Gilbert, E Sanders-Buell, L Heath, AC deCamp, CC Magaret, M Bose, A Bradfield, A O'Sullivan, J Crossler, W Deng, H Zhao, K Wong, DN Raugi, J Hural…

Citation: Retrovirology 2009 6(Suppl 3):O42

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection

Authors: MK Liu, G Ferrari, J Salazar, B Keele, RL Tanner, P Hraber, E Giorgi, VV Ganusov, GH Learn, MG Salazar, SR Moore, K Digleria, Z Yu, T Rostron, C DeBoer, A Williams…

Citation: Retrovirology 2009 6(Suppl 3):O40

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA06-02. Monospecific expansion of SIVmac251 during acute infection masks multiple transmitted virus variants revealed during the chronic phase

Authors: BK Felber, E Kim, R Pal, RC Desrosiers, SM Wolinsky and GN Pavlakis

Citation: Retrovirology 2009 6(Suppl 3):O38

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Authors: LR Baden, R Dolin, KL O'Brien, P Abbink, A La Porte, MS Seaman, E Choi, R Tucker, M Weitjens, MG Pau, J Goudsmit and DH Barouch

Citation: Retrovirology 2009 6(Suppl 3):O36

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites

Authors: N Strbo, M Vaccari, S Pahwa, MA Kolber, E Fisher, L Gonzalez, BK Felber, GN Pavlakis, G Franchini and ER Podack

Citation: Retrovirology 2009 6(Suppl 3):O34

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine

Authors: J Liu, N Ngai, GW Stone, F Yue and MA Ostrowski

Citation: Retrovirology 2009 6(Suppl 3):P11

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles

Authors: R Zuniga, B Mothe, A Llano, J Ibarrondo, M Daniels, M Farfan, J Suarez, JJ Szinger, W Hildebrand, A Lucchetti, D Heckerman, P Goulder, BD Walker, J Sanchez, BT Korber and C Brander

Citation: Retrovirology 2009 6(Suppl 3):O3

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

Retrovirology

Contact us